A theme focused on advancing regulatory applications and the transfer of sales rights to Cosmic Corporation, seeking regulatory approval, and pursuing in-house manufacturing for CTP testing, with the aim of commercializing in vitro diagnostic reagents using ELISA and immunochromatography.